Global Preclinical Imaging Market 2015-2019

#Snapshot img { margin: 10px !important; } About Pre-clinical Imaging Pre-clinical Imaging is in vivo imaging of small animals, which had been progressively deployed in drug development process. It helps in the visualizing and monitoring of animals for research with respect to tissue, organ, cell (at molecular level), and physiological and environmental changes. One of the main application areas of pre-clinical imaging is early detection of diseases. Currently the most used imaging modalities are optical (fluorescence and bioluminescence), PET, and MRI. In addition, multi-modalities such as PET+CT and SPECT+CT are the most used imaging combinations. In vivo imaging is increasingly used in target identification, compound optimisation and pre-Phase I studies, and in the drug development process. Thus, it bridges the gap between in vitro exploratory and in vivo clinical research. TechNavio's analysts forecast the Global Pre-clinical Imaging market to grow at a CAGR of 15.02 percent over the period 2014-2019.Covered in this ReportThis report covers the present scenario and growth prospects of the Global Pre-clinical Imaging market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of pre-clinical imaging systems. Pre-clinical imaging systems can be segmented based on the type of equipment, as mentioned below:• Micro MRI• Micro-PET• Micro-CT• PAT• SPECT• Multi-modality• Optical Imaging• UltrasoundThe report presents the vendor landscape and a corresponding detailed analysis of the top seven vendors in the Global Pre-clinical Imaging market. The vendor landscape in this report focuses on the vendors that provide access to new and technologically advanced pre-clinical imaging systems. The report also outlines the challenges faced by the vendors and the market at large, as well as the key trends emerging in the market.TechNavio's report, Global Pre-clinical Imaging Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Pre-clinical Imaging market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.Key Regions• Americas• APAC• EMEA       Key Vendors• Aspect Imaging• Bioscan (Subsidiary of Trifoil Imaging)• Bruker Corporation• Mediso Medical Imaging Systems• PerkinElmer• Siemens Healthcare• Thermo Fisher ScientificOther Prominent Vendor• Agilent Technologies• Capintec• Hitachi Medical• LI-COR Biosciences• Miltenyi Biotec GMBH• Naviscan• Positron• Promega• QuintilesMarket Driver• Increased R&D activities in Pharma Companies• For a full, detailed list, view our reportMarket Challenge• High Cost• For a full, detailed list, view our reportMarket Trend• Use of Multi-modalities Imaging Systems• For a full, detailed list, view our reportKey Questions Answered in this Report• What will the market size be in 2019 and what will the growth rate be?• What are the key market trends?• What is driving this market?• What are the challenges to market growth?• Who are the key vendors in this market space?• What are the market opportunities and threats faced by the key vendors?• What are the strengths and weaknesses of the key vendors?You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

关于临床前成像
临床前成像是对小型动物进行的活体成像，其在药物研发过程中已逐步得到应用。该技术有助于对动物的组织、器官、细胞（分子水平）以及生理和环境变化进行可视化和监测。临床前成像的主要应用领域之一是疾病的早期检测。目前最常用的成像方式包括光学成像（荧光和生物发光）、正电子发射断层扫描（PET）和磁共振成像（MRI）。此外，多模态成像如PET+CT和SPECT+CT也是应用最为广泛的成像组合。活体成像在靶点识别、化合物优化和临床前I期研究，以及药物研发过程中得到越来越广泛的应用，从而在体外探索研究和活体临床研究之间架起了一座桥梁。
TechNavio的分析师预测，全球临床前成像市场在2014-2019年期间将以15.02%的复合年增长率增长。本报告涵盖2015-2019年全球临床前成像市场的现状及增长前景。为了计算市场规模，报告考虑了临床前成像系统销售所获得的收入。临床前成像系统可以根据设备类型进行划分，如下所述：
• 微型MRI
• 微型PET
• 微型CT
• PAT
• SPECT
• 多模态
• 光学成像
• 超声波
报告展示了供应商格局以及对全球临床前成像市场中前七位供应商的详细分析。本报告中的供应商格局专注于提供接入新技术和先进临床前成像系统的供应商。报告还概述了供应商和市场所面临的挑战，以及市场中的主要趋势。
TechNavio的《2015-2019年全球临床前成像市场》报告基于对市场的深入分析以及行业专家的输入而编制。报告涵盖了美洲、EMEA和APAC地区；同时，它还涵盖了全球临床前成像市场格局及其未来几年的增长前景。报告还包括了在该市场中运营的关键供应商的讨论。
关键区域
• 美洲
• APAC
• EMEA
关键供应商
• Aspect Imaging
• Bioscan（Trifoil Imaging的子公司）
• Bruker Corporation
• Mediso Medical Imaging Systems
• PerkinElmer
• Siemens Healthcare
• Thermo Fisher Scientific
其他主要供应商
• Agilent Technologies
• Capintec
• Hitachi Medical
• LI-COR Biosciences
• Miltenyi Biotec GMBH
• Naviscan
• Positron
• Promega
• Quintiles
市场驱动因素
• 药企研发活动的增加
• 详细列表请参阅我们的报告
市场挑战
• 成本高昂
• 详细列表请参阅我们的报告
市场趋势
• 多模态成像系统的应用
• 详细列表请参阅我们的报告
本报告中回答的关键问题
• 2019年的市场规模将是多少？增长率是多少？
• 关键市场趋势是什么？
• 驱动该市场的是什么？
• 市场增长面临哪些挑战？
• 该市场空间中的关键供应商是谁？
• 关键供应商面临的市场机遇和威胁是什么？
• 关键供应商的优势和劣势是什么？
购买本市场报告时，您可以免费获得我们分析师一小时的咨询服务。详细信息请参阅报告。